Atlas Trials

Effects of Intranasal Nerve Growth Factor for Acute Ischemic Stroke

Clinical trial NCT03686163 · COMPLETED

Trial details

NCT number
NCT03686163
Sponsor
Jinling Hospital, China
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Acute Ischemic Stroke
Start date
2016-01-01
Primary completion
2019-12-31
Enrollment
106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.